A Abdel-Gadir1, L Schneider1, A Casini2, L-M Charbonnier1, S V Little1, T Harrington1, D T Umetsu3, R Rachid1, T A Chatila1. 1. Division of Immunology, Boston Children's Hospital and the Department of Pediatrics, Harvard Medical School, Boston, MA, USA. 2. Division of Immunology, Section of Pediatrics, Department of Health Sciences, University of Florence and Anna Meyer Children's Hospital, Florence, Italy. 3. Genentech, South San Francisco, CA, USA.
Abstract
BACKGROUND: Oral immunotherapy (OIT) successfully desensitizes patients with food allergies, but the immune mechanisms mediating its efficacy remain obscure. OBJECTIVES: We tested the hypothesis that allergen-specific regulatory T (Treg) cell function is impaired in food allergy and is restored by anti-IgE antibody (omalizumab)-supplemented OIT. METHODS: Peanut-specific T effector (Teff) and Treg cell proliferative responses, activation markers and cytokine expression were analysed by flow cytometry in 13 peanut-allergic subjects before the start of omalizumab-supplemented OIT and periodically in some subjects thereafter for up to 2 years. Peripheral blood regulatory T cells (Treg cells) were analysed for their peanut-specific suppressor function before and at 1 year following OIT. This study was registered on ClinicalTrials.gov (NCT01290913). RESULTS: Proliferation of allergen-specific Teff and Treg cells precipitously declined following the initiation of omalizumab therapy prior to OIT, followed by partial recovery after the initiation of OIT. At baseline, peanut-specific Treg cells exhibited a Th2 cell-like phenotype, characterized by increased IL-4 expression, which progressively reversed upon OIT. Peanut-specific Treg cell suppressor activity was absent at the start of omalizumab/OIT therapy but became robust following OIT. Absent peanut-specific Treg cell function could also be recovered by the acute blockade of IL-4/IL-4R receptor signalling in Treg cells, which inhibited their IL-4 production. CONCLUSIONS AND CLINICAL RELEVANCE: OIT supplemented by omalizumab promotes allergen desensitization through an initial omalizumab-dependent step that acutely depletes allergen-reactive T cells, followed by an increase in allergen-specific Treg cell activity due to the reversal of their Th2 cell-like programme. Improved Treg cell function may be a key mechanism by which OIT ameliorates food allergy.
BACKGROUND: Oral immunotherapy (OIT) successfully desensitizes patients with food allergies, but the immune mechanisms mediating its efficacy remain obscure. OBJECTIVES: We tested the hypothesis that allergen-specific regulatory T (Treg) cell function is impaired in food allergy and is restored by anti-IgE antibody (omalizumab)-supplemented OIT. METHODS:Peanut-specific T effector (Teff) and Treg cell proliferative responses, activation markers and cytokine expression were analysed by flow cytometry in 13 peanut-allergic subjects before the start of omalizumab-supplemented OIT and periodically in some subjects thereafter for up to 2 years. Peripheral blood regulatory T cells (Treg cells) were analysed for their peanut-specific suppressor function before and at 1 year following OIT. This study was registered on ClinicalTrials.gov (NCT01290913). RESULTS: Proliferation of allergen-specific Teff and Treg cells precipitously declined following the initiation of omalizumab therapy prior to OIT, followed by partial recovery after the initiation of OIT. At baseline, peanut-specific Treg cells exhibited a Th2 cell-like phenotype, characterized by increased IL-4 expression, which progressively reversed upon OIT. Peanut-specific Treg cell suppressor activity was absent at the start of omalizumab/OIT therapy but became robust following OIT. Absent peanut-specific Treg cell function could also be recovered by the acute blockade of IL-4/IL-4R receptor signalling in Treg cells, which inhibited their IL-4 production. CONCLUSIONS AND CLINICAL RELEVANCE: OIT supplemented by omalizumab promotes allergen desensitization through an initial omalizumab-dependent step that acutely depletes allergen-reactive T cells, followed by an increase in allergen-specific Treg cell activity due to the reversal of their Th2 cell-like programme. Improved Treg cell function may be a key mechanism by which OIT ameliorates food allergy.
Authors: Oliver T Burton; Stephanie L Logsdon; Joseph S Zhou; Jaciel Medina-Tamayo; Azza Abdel-Gadir; Magali Noval Rivas; Kyle J Koleoglou; Talal A Chatila; Lynda C Schneider; Rima Rachid; Dale T Umetsu; Hans C Oettgen Journal: J Allergy Clin Immunol Date: 2014-07-16 Impact factor: 10.793
Authors: Pamela A Frischmeyer-Guerrerio; Madhan Masilamani; Wenjuan Gu; Erica Brittain; Robert Wood; Jennifer Kim; Kari Nadeau; Kirsi M Jarvinen; Alexander Grishin; Robert Lindblad; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2017-04-13 Impact factor: 10.793
Authors: Philippe A Eigenmann; Kirsten Beyer; A Wesley Burks; Gideon Lack; Chris A Liacouras; Jonathan O'B Hourihane; Hugh A Sampson; Eva Sodergren Journal: Pediatr Allergy Immunol Date: 2008-08 Impact factor: 6.377
Authors: Wayne G Shreffler; Niya Wanich; Marla Moloney; Anna Nowak-Wegrzyn; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2009-01 Impact factor: 10.793
Authors: Udo Baron; Stefan Floess; Georg Wieczorek; Katrin Baumann; Andreas Grützkau; Jun Dong; Andreas Thiel; Tina J Boeld; Petra Hoffmann; Matthias Edinger; Ivana Türbachova; Alf Hamann; Sven Olek; Jochen Huehn Journal: Eur J Immunol Date: 2007-09 Impact factor: 5.532
Authors: R Sharon Chinthrajah; Joseph D Hernandez; Scott D Boyd; Stephen J Galli; Kari C Nadeau Journal: J Allergy Clin Immunol Date: 2016-04 Impact factor: 10.793
Authors: Deborah M Hussey Freeland; Hua Fan-Minogue; Jonathan M Spergel; Talal A Chatila; Kari C Nadeau Journal: Curr Opin Immunol Date: 2016-10-13 Impact factor: 7.486
Authors: Monali Manohar; Diane Dunham; Sheena Gupta; Zheng Yan; Wenming Zhang; Samantha Minnicozzi; Matthew Kirkey; Bryan Bunning; Roshni Roy Chowdhury; Stephen J Galli; Scott D Boyd; Laurie Elizabeth Kost; R Sharon Chinthrajah; Manisha Desai; Hans C Oettgen; Holden T Maecker; Wong Yu; Rosemarie H DeKruyff; Sandra Andorf; Kari C Nadeau Journal: Allergy Date: 2021-05-29 Impact factor: 14.710
Authors: Jacob A Turner; Emmanuel Stephen-Victor; Sen Wang; Magali Noval Rivas; Azza Abdel-Gadir; Hani Harb; Ye Cui; Manoussa Fanny; Louis-Marie Charbonnier; Jason Jun Hung Fong; Mehdi Benamar; Leighanne Wang; Oliver T Burton; Kushagra Bansal; Lynn Bry; Chengsong Zhu; Quan-Zhen Li; Rachel L Clement; Hans C Oettgen; Elena Crestani; Rima Rachid; Peter T Sage; Talal A Chatila Journal: Immunity Date: 2020-10-20 Impact factor: 31.745